A Double-blind, Placebo-controlled Evaluation of the Effect of the Erchonia® EVRL on Chronic Jaw Pain Arising From TMJ

Part of paid clinical trials in Acton, Massachusetts.

Sponsor
Erchonia Corporation
Study ID
NCT07600203
Status
Recruiting
Apply to this trial

Conditions

  • TMD
  • TMJ
  • TMJ Pain

Eligibility Criteria

Sex
ALL
Age
22 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • Erchonia® EVRL™ — DEVICE
    The Erchonia® EVRL™ is a handheld device containing one 635 nm red laser diode and one 405 nm violet laser diode. During treatment, the diodes are positioned approximately 3 to 4 inches from the skin over the temporomandibular joint area. Treatment is administered for a total of 16 minutes, with 8 minutes applied to each side.
  • Placebo Device — DEVICE
    The Placebo Laser has the same appearance as the Erchonia® EVRL™ but does not emit any therapeutic light. During treatment, the diodes are positioned approximately 3 to 4 inches from the skin over the temporomandibular joint area. Treatment is administered for a total of 16 minutes, with 8 minutes applied to each side.

Study Details

The purpose of this clinical study is to determine the effectiveness of the Erchonia EVRL, manufactured by Erchonia Corporation (the Company), in providing temporary relief of nociceptive musculoskeletal chronic jaw pain arising from temporomandibular joint (TMJ).

Key Dates

Start date
May 14, 2026
Status verified
May 2026
Primary completion
Dec 21, 2027
Completion
Dec 22, 2027

Study Design

Enrollment
64 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Erchonia® EVRL™
    The Erchonia® EVRL™ is made up of (1) 635 nanometers red laser diode and (1) 405 nanometers violet laser diode mounted in a portable handheld device.
  • Placebo Comparator: Placebo Laser
    The Placebo Laser has the same appearance as the Erchonia® EVRL™ but does not emit any therapeutic light.

Primary Outcome Measure

Number of Participants With a 30% or Greater Change in Pain Rating on the Visual Analog Scale (VAS) [ Time Frame: Baseline and immediately after treatment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Acton Dental AssociatesActonMassachusetts01720-5774
Eric Block, DMD
978-263-3526

Find similar trials in Acton, MA

By research site
Acton Dental Associates· Acton, MA

Related Studies